Antifungal activity of the extract of Curcuma zedoaria against yeasts of the genus Candida isolated from the oral cavity of patients infected with the human immunodeficiency virus

Revista Brasileira de Farmacognosia

Volumn 21, Issue 1, 2011, Pages 128-132

  Shinobu Mesquita, Cristiane S ^a   Bertoni, Thâmara A ^a   Guilhermetti, Eliana ^a   Svidzinski, Terezinha I E ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antifungal activity; Candida albicans; Curcuma zedoaria; Oral candidosis

Indexed keywords

ALCOHOL; CURCUMA ZEDOARIA EXTRACT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CURCUMA ZEDOARIA; DRUG SYNTHESIS; FUNGUS ISOLATION; HUMAN IMMUNODEFICIENCY VIRUS; MEDICINAL PLANT; MOUTH CAVITY; NONHUMAN; YEAST;

EID: 79954565004     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2011005000017     Document Type: Article

References (24)

1. Antunes Jr D 2002. Farmácia de Manipulação, Noções básicas. 1° Ed. São Paulo: Tecnopress, p.117.
2. Bachmann SP, Patterson TF, Ribot JL 2002. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microb 40: 2228-2230.
3. Bugno A, Nicoletti MA, Almodóvar AAB, Pereira TC, Auricchio MT 2007. Antimicrobial efficacy of Curcuma zedoaria extract as assessed by linear regression compared with commercial mouthrinses. Braz J Microbiol 38: 440-445.
4. Campos J, Del Romero J, Castilha J, Garcia S, Rodriguez C, Bascones A 2002. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lynphocyte percentage in HIV-infected patients. J Oral Pathol Med 31: 5-10.
5. a. Ed. NCCLS document M27-A2 [ISBN 1-56238-469-4]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 Estados Unidos, 2002.
6. Dota KFD, Shinobu CS, Patussi EV, Consolaro MEL, Svidzinski TIE 2008. Susceptibilidad de levaduras vaginales a los antifúngicos más utilizados em Maringá, Paraná, Brasil. Acta Bioquím Cliín Latinoam 42: 561-566.
7. Duarte MT, Figueira M, Sartoratto A, Rehder VL, Delarmina C 2004. Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol 97: 305-311.
8. Ferrazza MHSH, Maluf MLF, Consolaro MEL, Shinobu CS, Svidzinski TIE, Batista MR 2005. Caracterização de leveduras isoladas da vagina e sua associação com candidíase vulvovaginal em duas cidades do sul do Brasil. Rev Bras Ginecol Obstet 27: 58-63.
9. Ficker CE, Smit, ML, Susiarti S, Leaman DJ, Irawati Ç, Arnason JT 2003. Inhibition of human pathogenic fungi by members of Zingiberaceae used by the Kenyah (Indonesian Borneo). J of Ethnopharmacol 85: 289-293.
10. Fidel PL Jr 2002. Immunity to Candida. Oral Dis 8 Suppl 2: 69-75.
11. Gupta SK, Baneriee AB, Achari B 1976. Isolation of Ethyil p-methoxycinnamate, the major antifungal principle of Curcuma zedoaria. Lloydia 39: 218-222.
12. Kurtzman CP, Fell JW 1998. The Yeast. A taxonomic study. Amsterdam: Elsevier.
13. Laet Sant'Ana P, Milan EP, Martinez R, Queiroz-TellesTelles FQ, Ferreira MS, Alcântara MTC, Carvalho MT, Colombo AL. et al 2002. Multicenter Brazilian study of oral Candida species isolated from Aids patients. Mem I Oswaldo Cruz 97: 253-257.
14. Larone DH 1995. Medically important fungi. A guide to identification. Washington: AMS Press.
15. Lobo R, Prabhu KS, Shirwaikar A, & Shirwaikar A 2009. Curcuma zedoaria Rosc. (with turmeric): a review of its chemical, pharmacological and ethnomedicinal properties. J Pharm Pharmacol 61: 13-21.
16. Matsuda H, Morikawa T, Ninomiya K, Yoshikawa M 2001. Absolute stereostructure of carabrane-type sesquiterpene and vasorelaxant-active from Zedoariae Rizoma. Tetrahedron 57: 8443-8453.
17. Nadkarni KM 1999. Indian Materia Medica, 3rd edn. Mumbai, India: Popular Prakashan Private Limited.
18. Pádua RAF, Guilhermetti E, Svidzinski TIE 2003. In vitro activity of antifungal agents on yeasts isolated from vaginal secretion. Acta Scientiarum 25: 51-54.
19. Powderly WG, Robinson K, Keath EJ 1993. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis 168: 463-466.
20. Queiroz-Telles F, Silva N, Carvalho MM, Alcântara AP, da Matta D, Barberino MG, Bartczak S, Colombo AL. 2002. Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS pacients. Braz J of Infec Dis 5: 60-66.
21. Rex JH, Rinald MG, Pfaller MA 1995. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39: 1-8.
22. Sandrini JC, Navarro DF, Rocha JCF, Ribeiro PG, & Kozlowski Jr VA 1997. Efeitos do extrato de Curcuma zedoaria sobre a placa dental e gengivite em humanos-Avaliação clínica. Revista Periodontia 6: 3-6.
23. Schechter M, Rachid M 2004. Manual de HIV/Aids. Rio de Janeiro. Revinter.
24. Singh G, Singh OP, Maurya S 2002. Chemical and biocidal investigations on essencial oils of some Indian Curcuma species. Prog Cryst Growth Charact Mater 45: 75-81.